Pipeline Therapeutics is a biopharmaceutical company focused on the development and commercialization of first-in-class small molecules for neuroregeneration, including synaptogenesis, remyelination and axonal repair. The company’s lead product candidate, PIPE-505, is a small molecule gamma secretase inhibitor (GSI) to treat mild-to-moderate sensorineural hearing loss (SNHL) associated with cochlear synaptopathy. The company also has a portfolio of programs, including PIPE-307, focused on remyelination and axonal repair, to address a range of neurological disorders, including multiple sclerosis.
Location: United States, California, San Diego
Employees: 11-50
Total raised: $110M
Founded date: 2017
Investors 2
| Date | Name | Website |
| - | Red Tree V... | redtreevc.... |
| - | Hadean Ven... | hadeanvent... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 12.02.2021 | Series C | $80M | - |
| 18.12.2019 | Series B | $30M | - |
Mentions in press and media 15
| Date | Title | Description |
| 05.04.2024 | Contineum Therapeutics formally known as Pipeline Therapeutics raises $110M from IPO | - |
| 07.11.2022 | Vivo Capital Invests in Zenas Biopharma’s $118 Million Financing to Advance the Company’s Broad Pipeline of Autoimmune Disease Therapeutics | - |
| 12.02.2021 | Daily funding roundup - February 11th, 2021 | Zocdoc raised $150M; Modern Health landed $74M; Human Interest secured $55M; WireWheel picks up $20M Zocdoc: Zocdoc is a digital healthcare scheduling platform. Zocdoc has raised $150 million in fresh funding led by Francisco Partners. Read... |
| 12.02.2021 | Pipeline Therapeutics closes $80M Series C | Pipeline Therapeutics has raised $80 million from investors including Perceptive Advisors, Casdin Capital, Samsara BioCapital and Red Tree Venture Capital. The San Diego-based company is developing regenerative therapies intended to treat n... |
| 11.02.2021 | Pipeline Therapeutics Completes $80 Million Series C Financing | - |
| 11.02.2021 | Pipeline Therapeutics Finds $80M In Series C Funding | San Diego-based Pipeline Therapeutics, a biopharmaceuticals firm focused on small molecules for neuroregeneration, said on Thursday that it has raised $80M in its Series C funding. The funding included Perceptive Advisors, Franklin Templeto... |
| 11.02.2021 | Pipeline Therapeutics Nabs $80M Series C | SAN DIEGO, CA, Pipeline Therapeutics today announced the closing of an $80 million Series C financing. >> Click here for more funding data on Pipeline Therapeutics >> To export Pipeline Therapeutics funding data to PDF and E... |
| 11.02.2021 | Pipeline Therapeutics banks $80M to propel hearing loss, MS programs | Nearly three years after launch, Versant Ventures spinout Pipeline Therapeutics is banking $80 million to push its lead neurodegenerative disease programs through the clinic. The funds will bankroll clinical trials for programs in hearing l... |
| 11.02.2021 | Pipeline Therapeutics Completes $80 Million Series C Financing | Pipeline Therapeutics – News – 02/11/2021 |
| 11.02.2021 | Pipeline Therapeutics has raised an $80M Series C to advance its clinical programs and accelerate discovery efforts | - |
Show more